Remyelination protects axons from demyelination-associated axon degeneration.

In multiple sclerosis, demyelination of the CNS axons is associated with axonal injury and degeneration, which is now accepted as the major cause of neurological disability in the disease. Although the kinetics and the extent of axonal damage have been described in detail, the mechanisms by which it occurs are as yet unclear; one suggestion is failure of remyelination. The goal of this study was to test the hypothesis that failure of prompt remyelination contributes to axonal degeneration following demyelination. Remyelination was inhibited by exposing the brain to 40 Gy of X-irradiation prior to cuprizone intoxication and this resulted in a significant increase in the extent of axonal degeneration and loss compared to non-irradiated cuprizone-fed mice. To exclude the possibility that this increase was a consequence of the X-irradiation and to highlight the significance of remyelination, we restored remyelinating capacity to the X-irradiated mouse brain by transplanting of GFP-expressing embryo-derived neural progenitors. Restoring the remyelinating capacity in these mice resulted in a significant increase in axon survival compared to non-transplanted, X-irradiated cuprizone-intoxicated mice. Our results support the concept that prompt remyelination protects axons from demyelination-associated axonal loss and that remyelination failure contributes to the axon loss that occurs in multiple sclerosis.

[1]  K. Irvine,et al.  A different regional response by mouse oligodendrocyte progenitor cells (OPCs) to high‐dose X‐irradiation has consequences for repopulating OPC‐depleted normal tissue , 2007, The European journal of neuroscience.

[2]  W. F. Blakemore,et al.  Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.

[3]  Blakemore Wf,et al.  Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. , 2006 .

[4]  T. Kilpatrick,et al.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Blakemore,et al.  Repopulation of oligodendrocyte progenitor cell‐depleted tissue in a model of chronic demyelination , 2005, Neuropathology and applied neurobiology.

[6]  G. Comi,et al.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.

[7]  S. Skaper,et al.  Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor‐dependent and ‐independent mechanisms , 2004, Journal of neurochemistry.

[8]  E. Brand-Schieber,et al.  Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis , 2004, Experimental Neurology.

[9]  I. Duncan,et al.  Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.

[10]  H. Keirstead,et al.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis , 2004, Experimental Neurology.

[11]  W. Blakemore,et al.  Suppression of remyelination in the CNS by X-irradiation , 1978, Acta Neuropathologica.

[12]  T. Ben-Hur,et al.  Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis , 2003, Molecular and Cellular Neuroscience.

[13]  D. Offen,et al.  Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis , 2003, Neuroscience Research.

[14]  T. Kawakami,et al.  Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms , 2003, The Journal of Neuroscience.

[15]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[16]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[17]  W. Blakemore,et al.  Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue , 2003, Journal of neuroscience research.

[18]  Robert Layfield,et al.  Oligodendrocytes Promote Neuronal Survival and Axonal Length by Distinct Intracellular Mechanisms: A Novel Role for Oligodendrocyte-Derived Glial Cell Line-Derived Neurotrophic Factor , 2003, The Journal of Neuroscience.

[19]  K. Nave,et al.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.

[20]  T. Grune,et al.  Impairment of protein homeostasis and decline of proteasome activity in microglial cells from adult Wistar rats , 2003, Journal of neuroscience research.

[21]  A. Crosby,et al.  Is the transportation highway the right road for hereditary spastic paraplegia? , 2002, American journal of human genetics.

[22]  Melitta Schachner,et al.  Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.

[23]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[24]  W. Blakemore,et al.  New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation , 2002, Multiple sclerosis.

[25]  T. Montine,et al.  In Vivo Assessment of Lipid Peroxidation Products Associated with Age-Related Neurodegenerative Diseases , 2002, Experimental Neurology.

[26]  H. Lassmann,et al.  CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation , 2002, Nature Medicine.

[27]  A. Crang,et al.  Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS , 2002, Glia.

[28]  Chao Zhao,et al.  The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.

[29]  S. Waxman Sodium channels as molecular targets in multiple sclerosis. , 2002, Journal of rehabilitation research and development.

[30]  D. Westaway,et al.  Phenotypic and functional changes in glial cells as a function of age , 2002, Neurobiology of Aging.

[31]  A Compston,et al.  A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons , 2001, Glia.

[32]  Scott T. Brady,et al.  Changes in Microtubule Stability and Density in Myelin-Deficient Shiverer Mouse CNS Axons , 2001, The Journal of Neuroscience.

[33]  R. Franklin,et al.  Depletion of endogenous oligodendrocyte progenitors rather than increased availability of survival factors is a likely explanation for enhanced survival of transplanted oligodendrocyte progenitors in X‐irradiated compared to normal CNS , 2001, Neuropathology and applied neurobiology.

[34]  R. Franklin,et al.  Delayed Changes in Growth Factor Gene Expression during Slow Remyelination in the CNS of Aged Rats , 2000, Molecular and Cellular Neuroscience.

[35]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[36]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[37]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[38]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.

[39]  R. Franklin,et al.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination , 1999, Glia.

[40]  C. Svendsen,et al.  Mouse epidermal growth factor-responsive neural precursor cells increase the survival and functional capacity of embryonic rat dopamine neurons in vitro. , 1999, Neuroreport.

[41]  K. Unsicker,et al.  GDNF family members and their receptors: Expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development , 1999, Glia.

[42]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[43]  T. Morgan,et al.  Age-Related Activation of Microglia and Astrocytes: In Vitro Studies Show Persistent Phenotypes of Aging, Increased Proliferation, and Resistance to Down-Regulation , 1998, Neurobiology of Aging.

[44]  G. Wolswijk Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.

[45]  ichard,et al.  AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .

[46]  K. Smith,et al.  Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. , 1997, Brain : a journal of neurology.

[47]  V. Perry,et al.  Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke , 1997, Neuropathology and applied neurobiology.

[48]  H. Webster,et al.  Growth factors and myelin regeneration in multiple sclerosis , 1997, Multiple sclerosis.

[49]  S. Sakoda,et al.  Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.

[50]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[51]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[52]  J. Fawcett,et al.  Migration of oligodendrocyte precursors on astrocytes and meningeal cells. , 1995, Developmental biology.

[53]  S. Brady,et al.  Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  A. Campagnoni,et al.  Murine oligodendroglial cells express nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Giulian,et al.  Brain glia release factors with opposing actions upon neuronal survival , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  Scott T. Brady,et al.  Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.

[57]  J. Winn,et al.  Brain , 1878, The Lancet.

[58]  W. Carlton,et al.  Monoamine oxidase inhibition and the activity of other oxidative enzymes in the brains of mice fed cuprizone. , 1971, Toxicology and applied pharmacology.

[59]  I. Pattison,et al.  Clinical and histological observations on cuprizone toxicity and scrapie in mice. , 1971, Research in veterinary science.